EICHOR
● Terminated
Long-Term, Open Label Extension Study of Pemziviptadil (PB1046) in PAH Subjects Following Completion of Study PB1046-PT-CL-0004
Condition: Pulmonary Arterial Hypertension · Sponsor: PhaseBio Pharmaceuticals Inc.
About this study
This is a multi-center, Phase 2 Long-Term, Open Label Extension (OLE) Study to assess the safety and tolerability of pemziviptadil (PB1046) at an optimally titrated dose. This is a Long-Term, Open label Extension (OLE) Study for subjects with (PAH), having participated in double-blind Study PB1046-PT-CL-0004. The study will include adult subjects previously diagnosed with symptomatic PAH, who are receiving background clinician-directed therapy for PAH. During this period, subjects will continue to be followed for safety and tolerability, as well as for periodic efficacy, quality of life data and immunogenicity. The study will continue per the schedule of events until such time when pemziviptadil (PB1046) is able to be self-administered, becomes commercially available to the subjects in a particular country or region, or the sponsor terminates the study due to lack of efficacy, safety or other reasons.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (16)
| University of California San Diego | La Jolla, California, United States | — |
| University of California - Davis | Sacramento, California, United States | — |
| University of Miami - Pulmonary Research Center | Miami, Florida, United States | — |
| Emory University, The Emory Clinic | Atlanta, Georgia, United States | — |
| University of Iowa Hospitals and Clinics | Iowa City, Iowa, United States | — |
| University of Kansas Medical Center | Kansas City, Kansas, United States | — |
| Tufts Medical Center | Boston, Massachusetts, United States | — |
| Brigham and Women's Hospital | Boston, Massachusetts, United States | — |
| NYU Langone Health | New York, New York, United States | — |
| University of Rochester Medical Center | Rochester, New York, United States | — |
| The Lindner Center for Research and Education at The Christ Hospital | Cincinnati, Ohio, United States | — |
| University of Cincinnati | Cincinnati, Ohio, United States | — |
+ 4 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03795428